Table 2.
Multivariate Cox regression model analysis for the MMSS (n = 286).
Variable | Level | Reference | HR (95% CI) | P-value |
---|---|---|---|---|
Patient cohort | Italy | Germany | 0.81 (0.51–1.30) | 0.385 |
Age* | 1.03 (1.01–1.06) | 0.001 | ||
Gender | Male | Female | 0.87 (0.48–1.58) | 0.645 |
Location | Non-OPSSC | OPSCC | 0.72 (0.45–1.14) | 0.162 |
Tumor size | T3-4 | T1-2 | 3.30 (1.73–6.29) | 3e-04 |
Lymph nodes | N+ | N0 | 2.02 (1.12–3.64) | 0.020 |
Distant metastasis | M+ | M0 | 5.91 (2.64–13.22) | <1e-04 |
Staging | S3-4 | S1-2 | 0.38 (0.14–1.01) | 0.052 |
Grading | G3 | G1-2 | 1.30 (0.86–1.95) | 0.209 |
First therapy | Surgery | No Surgery | 0.64 (0.40–1.01) | 0.055 |
HPV16 status | DNA+/RNA+ | DNA− or DNA+/RNA− | 0.71 (0.26–1.92) | 0.502 |
Alcohol status | Former or current | Never | 1.80 (0.97–3.34) | 0.062 |
Smoking status | Former or current | Never | 1.34 (0.73–2.46) | 0.342 |
MMSS | MMSS_p | MMSS_g | 2.15 (1.36–3.41) | 0.001 |
HR, hazard ratio; CI, confidence interval.
continuously